Morgan Stanley (MS) Shares Bought by Pinnacle Associates Ltd.

Share on StockTwits

Pinnacle Associates Ltd. boosted its position in Morgan Stanley (NYSE:MS) by 33.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 175,472 shares of the financial services provider’s stock after acquiring an additional 44,199 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Morgan Stanley were worth $6,957,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. CWM LLC boosted its holdings in Morgan Stanley by 72.6% in the fourth quarter. CWM LLC now owns 799 shares of the financial services provider’s stock valued at $32,000 after acquiring an additional 336 shares during the last quarter. San Francisco Sentry Investment Group CA boosted its holdings in Morgan Stanley by 63.7% in the fourth quarter. San Francisco Sentry Investment Group CA now owns 1,002 shares of the financial services provider’s stock valued at $39,000 after acquiring an additional 390 shares during the last quarter. Vigilant Capital Management LLC boosted its holdings in Morgan Stanley by 183.8% in the fourth quarter. Vigilant Capital Management LLC now owns 1,158 shares of the financial services provider’s stock valued at $46,000 after acquiring an additional 750 shares during the last quarter. Signet Investment Advisory Group Inc. acquired a new position in Morgan Stanley in the fourth quarter valued at $59,000. Finally, Girard Partners LTD. acquired a new position in shares of Morgan Stanley during the third quarter worth about $115,000. Hedge funds and other institutional investors own 85.67% of the company’s stock.

NYSE:MS opened at $40.81 on Monday. The company has a debt-to-equity ratio of 2.67, a quick ratio of 0.80 and a current ratio of 0.80. Morgan Stanley has a one year low of $36.74 and a one year high of $59.38. The stock has a market capitalization of $70.20 billion, a P/E ratio of 8.85, a price-to-earnings-growth ratio of 0.71 and a beta of 1.20.

Morgan Stanley (NYSE:MS) last released its quarterly earnings results on Thursday, January 17th. The financial services provider reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.90 by ($0.17). Morgan Stanley had a return on equity of 12.08% and a net margin of 17.43%. The business had revenue of $8.55 billion during the quarter, compared to analyst estimates of $9.32 billion. During the same quarter last year, the firm posted $0.84 EPS. The company’s revenue was down 10.0% compared to the same quarter last year. As a group, equities research analysts predict that Morgan Stanley will post 4.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 15th. Investors of record on Thursday, January 31st will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 2.94%. The ex-dividend date of this dividend is Wednesday, January 30th. Morgan Stanley’s dividend payout ratio (DPR) is 26.03%.

In related news, insider Jeffrey S. Brodsky sold 15,565 shares of the business’s stock in a transaction dated Friday, January 18th. The stock was sold at an average price of $43.38, for a total value of $675,209.70. Following the transaction, the insider now owns 112,420 shares in the company, valued at $4,876,779.60. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.19% of the company’s stock.

MS has been the topic of a number of recent research reports. UBS Group upgraded Morgan Stanley from a “market perform” rating to an “outperform” rating in a research note on Tuesday, October 16th. Oppenheimer upgraded Morgan Stanley to an “outperform” rating and set a $62.00 price objective on the stock in a research note on Tuesday, October 16th. Vining Sparks restated a “buy” rating and set a $60.00 price objective on shares of Morgan Stanley in a research note on Tuesday, October 16th. Wells Fargo & Co upgraded Morgan Stanley from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $56.00 to $60.00 in a research note on Wednesday, October 24th. Finally, Zacks Investment Research upgraded Morgan Stanley from a “hold” rating to a “buy” rating and set a $50.00 price objective on the stock in a research note on Tuesday, November 20th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $56.38.

WARNING: This report was first reported by Zolmax and is owned by of Zolmax. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://zolmax.com/investing/morgan-stanley-ms-shares-bought-by-pinnacle-associates-ltd/2891781.html.

Morgan Stanley Company Profile

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company operates Institutional Securities, Wealth Management, and Investment Management segments.

Featured Article: Book Value Per Share – BVPS

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Kraft Heinz Co  Shares Sold by Reaves W H & Co. Inc.
Kraft Heinz Co Shares Sold by Reaves W H & Co. Inc.
JNBA Financial Advisors Takes Position in VanEck Vectors Wide Moat ETF
JNBA Financial Advisors Takes Position in VanEck Vectors Wide Moat ETF
Sun Life Financial Inc  Holdings Reduced by Stevens First Principles Investment Advisors
Sun Life Financial Inc Holdings Reduced by Stevens First Principles Investment Advisors
Smith Asset Management Group LP Cuts Position in Sinopec Shanghai Petrochemical Co.
Smith Asset Management Group LP Cuts Position in Sinopec Shanghai Petrochemical Co.
Science Applications International Corp  Holdings Trimmed by Smith Asset Management Group LP
Science Applications International Corp Holdings Trimmed by Smith Asset Management Group LP
Smith Asset Management Group LP Has $1.76 Million Position in USANA Health Sciences, Inc.
Smith Asset Management Group LP Has $1.76 Million Position in USANA Health Sciences, Inc.


Leave a Reply

 
© 2006-2019 Zolmax.